University of Massachusetts, Worcester

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Massachusetts, Worcester sits in the top decile of US sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count).

240 total trials 30 currently recruiting 177 completed early-phase tilt top decile by trial count

University of Massachusetts, Worcester: 240 sponsored US clinical trials, 30 recruiting.

University of Massachusetts, Worcester sponsors 240 registered US clinical trials on ClinicalTrials.gov, 30 of them currently recruiting, and 177 completed. 23 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Use Disorder, with 4 trials.

Top-decile sponsor footprint

University of Massachusetts, Worcester ranks in the top decile of sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 71/100

177 of 191 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

240 total, page 4 of 5

TERMINATED Phase 1

Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia

NCT02047149
COMPLETED NA

A Randomized Trial of Outpatient Oxygen Weaning Strategies in Premature Infants

NCT01994954
COMPLETED NA

Vitamin D Supplementation for Bipolar Depression

NCT01884844
COMPLETED Phase 1

Project HERA (Health, Education, and Relationship-building for Adolescents- Moms and Tots)

NCT02200484
COMPLETED Phase 1

Pediatric Practice-based Obesity Intervention to Support Families: FITLINE

NCT02085434
TERMINATED

Sonographic Features of Cellulitis and Failure of Therapy

NCT01773499
COMPLETED Phase 2

School Nurse Intervention and After School Exercise Program for Overweight Teens

NCT01463124
COMPLETED NA

Pilot Investigation of Behavioral Alternatives to Indoor Tanning

NCT02192918
COMPLETED NA

Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial

NCT01583166
COMPLETED Phase 2

Endothelial Facilitation in Alzheimer's Disease

NCT01439555
COMPLETED NA

CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes

NCT01416766
COMPLETED Phase 4

Salsalate as an Adjunctive Treatment for Patients With Schizophrenia

NCT01578486
COMPLETED NA

The Mental Health and Dynamic Referral for Oncology Protocol (MHADRO)

NCT01442285
COMPLETED NA

Using Health Information Technology (HIT) to Improve Transitions of Complex Elderly Patients From Skilled Nursing Facility (SNF) to Home

NCT01004328
COMPLETED NA

Physiology and Therapeutic Management of Neonatal Abstinence Syndrome

NCT02768844
COMPLETED Phase 3

Adjunctive Metformin Therapy in Double Diabetes

NCT01334125
COMPLETED Phase 1

A Community-based Social Networking Intervention to Increase Walking in Dog Owners

NCT01593449
COMPLETED NA

iADAPT: Off Label Use of Antipsychotics in the Nursing Home

NCT01347619
COMPLETED NA

Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults

NCT01472354
COMPLETED NA

Improving Posthospital Medication Management of Older Adults Through Health IT

NCT00611091
COMPLETED

Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management

NCT01151709
COMPLETED NA

Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE)

NCT01150994
COMPLETED Phase 2

Dynamic Assessment and Referral System - Evaluation

NCT01153373
COMPLETED

The Use of Ultrasound to Measure Depth of Thoracic Epidural Space

NCT01172730
COMPLETED Phase 3

Does Coffee Consumption Prevent or Shorten Postoperative Ileus After Colon Resection?

NCT01130675
COMPLETED Phase 3

PETS-D (Parent Education Thru Simulation-Diabetes)

NCT01517269
COMPLETED NA

Web-delivered Provider Intervention for Tobacco Control

NCT00797628
COMPLETED NA

Patient Perception of Mammogram Guidelines

NCT01267877
COMPLETED

REASON 1 Trial: Sonography in Cardiac Arrest

NCT01446471
TERMINATED Phase 1

Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.

NCT01130688
COMPLETED Phase 2

Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults

NCT01052662
COMPLETED Phase 1

Safety Study of Dantrolene in Subarachnoid Hemorrhage

NCT01024972
COMPLETED Phase 1

Exercise Study to Help Patients Who Have Type 2 Diabetes and Depression.

NCT01024790
COMPLETED

Promoting Breast Cancer Screening in Non-adherent Women

NCT01332032
COMPLETED NA

Tobacco Treatment Medical Education in 10 Medical Schools

NCT01905618
COMPLETED Phase 2

A Mindfulness-based Intervention for Treatment of Anxiety in ICD (Implantable Cardioverter Defibrillator) Patients

NCT01035294
COMPLETED Phase 2

School Worksite Weight Gain Prevention Intervention Study

NCT01467284
COMPLETED NA

Vitamin D Supplementation in Psychiatric Illnesses

NCT01004354
COMPLETED NA

A Simple Dietary Message to Improve Dietary Quality for Metabolic Syndrome

NCT00911885
COMPLETED Phase 4

Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

NCT00981526
COMPLETED

Neuronal Processing of Diacritics: An fMRI Study

NCT00845806
COMPLETED NA

Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI

NCT00846287
TERMINATED Phase 1

Growth Hormone Therapy for Wasting in Cystic Fibrosis

NCT00803179
TERMINATED NA

Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders

NCT00846573
COMPLETED NA

Effective Communication for Preventing and Responding to Oncology Adverse Events

NCT01871948
COMPLETED NA

Immune Responses Induced by Different Licensed Influenza Vaccines

NCT00902278
COMPLETED Phase 1

A School Nurse-Delivered Intervention for Overweight and At Risk Adolescents

NCT00682188
COMPLETED Phase 3

Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses

NCT01085929
COMPLETED Phase 2

A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease

NCT01320527
COMPLETED

Vitamin D Deficiency and Low Bone Mineral Content in Children

NCT00756899
← Previous Page 4 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 24
Phase 2 14
Phase 3 11
Phase 4 12

Therapeutic Areas

Alcohol Use Disorder 4
Obesity 4
Vitamin D Deficiency 2
Schizoaffective Disorder 2
Preterm Birth 2
Type 2 Diabetes 2
Pregnancy, High Risk 2
Substance Use Disorders 2
Breast Cancer 2
Overweight 2

What is open in the University of Massachusetts, Worcester pipeline

30 recruiting of 240 indexed (13% open); 177 completed (74%).

Phase mix: 23 late (III/IV) vs 38 early (I/II) (early-phase heavy).

Top condition: Alcohol Use Disorder (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Massachusetts, Worcester: open-pipeline peers nationwide

Peers matched on 240 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 10%15%20%25% Total trials Recruiting share University of Massachusetts, WorcesterIncyte CorporationState University of New York at BuffaloLoma Linda UniversityDaiichi SankyoAddario Lung Cancer Medical InstituteAmerican UniversityAnnexonAnsun Biopharma
University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 240 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Massachusetts, Worcester page

240 registered trials is a research-attention snapshot, not an endorsement of University of Massachusetts, Worcester or any single study.

  • 30 of University of Massachusetts, Worcester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Alcohol Use Disorder is the condition University of Massachusetts, Worcester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Use Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Massachusetts, Worcester pipeline card: 240 registered trials from official public datasets.Report a data error.